Clinical and Diagnostic Laboratory Immunology
-
Publication Venue For
- Role of thromboxane A2 in the induction of apoptosis of immature thymocytes by lipopolysaccharide.. 12:896-903. 2005
- polyethylene glycol-conjugated adenosine deaminase (ADA) therapy provides temporary immune reconstitution to a child with delayed-onset ADA deficiency.. 12:861-866. 2005
- Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response.. 11:720-728. 2004
- Effect of pregnancy and human immunodeficiency virus infection on intracellular interleukin-2 production patterns.. 11:780-785. 2004
- Comparison of ophthalmic sponges for measurements of immune markers from cervical secretions.. 11:399-405. 2004
- Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.. 10:564-572. 2003
- Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients.. 9:1253-1259. 2002
- Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays.. 9:525-529. 2002
- Isolation and characterization of two European strains of Ehrlichia phagocytophila of equine origin.. 9:341-343. 2002
- Human lymphocyte proliferation responses following primary immunization with rabies vaccine as neoantigen.. 8:880-883. 2001
- Development of a novel screen for protease inhibitors.. 8:437-440. 2001
- T-Cell receptor Vbeta repertoire CDR3 length diversity differs within CD45RA and CD45RO T-cell subsets in healthy and human immunodeficiency virus-infected children.. 7:953-959. 2000
- Development of positive selectable markers for the fungal pathogen Cryptococcus neoformans.. 7:125-128. 2000
- Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection.. 6:718-724. 1999
- Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome.. 6:6-13. 1999
- Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency in common variable immunodeficiency.. 5:399-400. 1998
- Antibody responses to DNA in normal immunity and aberrant immunity.. 5:1-6. 1998
- Immunomagnetic selection of purified monocyte and lymphocyte populations from peripheral blood mononuclear cells following cryopreservation.. 4:653-658. 1997
- Evaluation of a method for counting absolute numbers of cells with a flow cytometer.. 4:309-313. 1997
- Inter- and intrainstitutional evaluation of automated volumetric capillary cytometry for the quantitation of CD4- and CD8-positive T lymphocytes in the peripheral blood of persons infected with human immunodeficiency virus. Site Investigators and the NIAID New CD4 Technologies Focus Group.. 4:173-179. 1997
- Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.. 3:378-386. 1996
- Molecular analysis of highly enriched populations of T-cell-depleted monocytes.. 2:733-739. 1995
- Determination of CD4 and CD8 lymphocyte subsets by a new alternative fluorescence immunoassay.. 2:330-336. 1995